Top 10 Deals of 2023: Pregnancy Care Company, Nuvo Group, merges with LAMF Global Ventures

Amboy Street Ventures’ Underserved Market series breaks down the history, developments and opportunities for the women’s health and sexual health markets. This week we take a look at menstruation and hormonal health.

VCs love big bets. Today we can confidently take them in sexual health and women’s health, as the space shifts from vice or niche to mainstream.

Amboy Street Ventures (ASV) is excited to announce its latest $1m investment in Aunt Flow to support the company’s plans to make free, 100% organic cotton period products available in every restroom, changing the world one cycle at a time.

Amboy Street Ventures (ASV) is excited to announce its latest $1m investment in Contraline, to enable the brand to conduct what is believed to be the first clinical trial on a non-hormonal male contraceptive device in over 20 years with its innovation ADAM™. The trial will launch the next generation of non-hormonal male contraceptives, increasing choice for men and achieving public health impact.

This week we look at companies in women’s health and sexual health that have been acquired by CPG conglomerates.

This week we look at the rise of M&A activity around women’s health and sexual health medical device innovations.

This week we discuss the rise of companies in our space joining the SPAC bandwagon.

This week we look at the growing demand for at-home birth control subscriptions.

This week we look at the incredible rise of successful companies in the menstrual market.